The Suno India ShowThe Suno India Show

Why a Covaxin Controversy in Bhopal is worrying trial participants, activists and experts

View descriptionShare

Bharat Biotech’s Covaxin is one of the two Indian vaccines being administered to healthcare workers as India embarks on the world’s largest inoculation drive. Health experts have expressed concerns as hundreds of Bhopal Gas Tragedy survivors say they had been enrolled in the clinical trial for Covaxin without their informed consent. One of the trial participants, Deepak Marabi, passed away on December 21, 2020. 

Join us on this episode of The Suno India Show, as our reporter Suryatapa Mukherjee explores the alleged violation of the rights of this vulnerable group as well as the alleged misconduct of the clinical trial. These participants say they weren’t adequately monitored and their adverse reactions to the vaccine weren’t properly recorded. 

She speaks to Rachna Dhingra, the activist with Bhopal Group of Information and Action who first tweeted about these ethical and legal violations. You will also hear from some of the trial participants, and Anant Bhan, who works in the field of bioethics and global health. 

Vice Chancellor Dr Rajesh Kapur’s statement
Bharat Biotech’s statement
National Ethical Guidelines
National Guidelines for Covid-19 Pandemic


Being an editorially independent platform, we rely on you to help us bring in untold stories that have the potential for social change. Do consider supporting us!

  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

  1. The Suno India Show

    391 clip(s)

The Suno India Show

The Suno India Show’ is a news show by Suno India combining slow journalism with under-represented a 
Social links
Follow podcast
Recent clips
Browse 391 clip(s)